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Thecomplex[ReOCl3pq](1)(wherepq=2-(2 pyridyl)quinoxaline)hasbeensynthesizedandfullycharacterizedbyUV-Vis,FTIR,
1 and 2D NMR, and cyclic voltammetry (CV). The DNA-binding properties of the complex 1 as well as of the compounds
[ReOCl3bpy] (2), [ReOCl3phen] (3), and pq (4) were investigated by UV-spectrophotometric (melting curves), CV (cyclic
voltammetry), and viscosity measurements. Experimental data suggest that complex 1 intercalates into the DNA base pairs. Upon
irradiation, complex 1 was found to promote the cleavage of plasmid pBR 322 DNA from supercoiled form I to nicked form II.
The mechanism of the DNA cleavage by complex 1 was also investigated.
1.Introduction
For many years transition metal complexes have piqued
curiosity owing to their eﬃcient DNA binding and cleavage
propertiesunderphysiologicalconditions[1–14].Ithasbeen
demonstrated that inorganic complexes can be used in foot-
printing studies, as sequence speciﬁc DNA binding agents, as
diagnostic agents in medicinal applications, and for genomic
research. Among diﬀerent modes of DNA cleavage, oxidative
cleavageofDNAuponirradiationwithvisiblelightisofmain
interest due to the potential applications of such compounds
in photodynamic therapy of cancer [3, 15] and references
therein.
On the other hand, coordination chemistry of rhenium
has been extensively developed in recent years due, to a
large extent, to the fact that its complexes with diimine
ligands display long lifetimes and also short-lived rhenium
isotopes hold promise as β-emitters in radiotherapy [14,
16, 17]. The chemistry of oxorhenium complexes arouses
particularinterestamongthesecompoundsnotonlyfortheir
implication in various reactions of industrial and biological
importance, including oleﬁn epoxidation and catalysis by
cytochrome P-450 [18, 19], but also for their lipophilic
character and the oxidation states of rhenium that is Re(I)
to Re (VI) [17].
In this context, the design, synthesis, and reactivity of
novel rhenium oxocomplexes have become the aim of several
laboratories, including ours. To the best of our knowledge,
studies on oxorhenium (V) complexes incorporating planar
aromatic ligands that could bind to DNA have not been
studied before. Nevertheless, quinoxaline (pq) has recently
received considerable attention [20, 21]. The structure of
the quinoxaline ligand is recognized from a great number of
natural compounds such as riboﬂavin and molybdopterines,
and can be used as antibacterial, antiviral, anticancer,
antihelmintic, and insecticidal agent [22]. In addition, it
adopts a planar conformation when chelates to a metal ion
[20, 23, 24]. This planar appendage provides a handle for
intercalative binding to DNA, positioning the complex for
enhanced reactivity toward DNA.
In this paper, we present the synthesis and character-
ization of the oxorhenium (V) complex, [ReOCl3pq] (1).
In order to elucidate the reactivity of this compound, we
have also synthesized the complexes [ReOCl3bpy] (2) and
[ReOCl3phen] (3) and studied their intercalating abilities.
The ligands (2 pyridyl)quinoxaline (4),2 , 2   bipyridine (5),2 Bioinorganic Chemistry and Applications
N
Re
O
N
Cl Cl
N
Cl
N
N
N
N
N
N
pq (4) bpy (5) phen (6)
WhereN −N:
pq = 1
bpy = 2
phen = 3
Figure 1: Structures of the complexes 1–3 and the corresponding
α-diimine ligands.
and 1-10-phenanthroline (6) belong to quinoxaline or
diimine class of organic compounds (Figure 1).
The interaction of these compounds with double
stranded calf thymus DNA has been investigated using
circular dichroism spectroscopy (CD), DNA thermal denat-
uration analysis (melting point), CV, and viscosity mea-
surements. The photocleavage reaction on DNA has been
monitored by agarose gel electrophoresis. Understanding the
interactions between the compounds under study and DNA,
and their ability to damage DNA with photoactivation by
visible light would be the ﬁrst step toward the development
of rhenium-based drugs which might be useful in photobio-
logical applications such as photodynamic therapy.
2. Experimental
2.1. Materials. 2-(2 -pyridyl)quinoxaline [25, 26]a n d
[ReOCl3(PPh3)2][ 27] were prepared by reported
procedures. All reactions and manipulations were conducted
under a pure argon atmosphere using standard Schlenk
techniques. Ultra-pure Milli-Q water (18.2mΩ)w a su s e d
in all experiments. Reagent grade solvents were dried and
distilled by usual methods and the solvents were stored over
molecular sieves (4˙ A). The chemicals were purchased by
Aldrich and used as received. Calf thymus DNA (CT DNA)
and pBR322 supercoiled plasmid DNA (stored at: −20◦C)
were purchased from Sigma (St. Louis, MO).
2.2. Methods and Instrumentation. Microanalysis (C, H, N)
was carried out with a Euro Vector EA 3000 analyser. FT-
IR spectra in solution and in KBr pellets were recorded
on a Nicolet Magna IR 560 spectrophotometer with a
1.0cm−1 resolution. UV-Vis spectroscopy was recorded on
a Varian Cary 300E spectrophotometer at 25 ± 0.2
◦C using
cuvettes of 1cm path length. The 1HNMR spectra were
obtained at room temperature using a Varian Unity Plus
300MHz spectrometer. Samples were run in a 5mm probe
with deuterated solvents as internal lock and reference. The
assignment of the 1HNMR spectra of the free ligands and
of the complexes is based on 2DNMR experiments (1H–1H
COSY). A Fisons VG Quattro instrument with a VG Biotech
Electrospraysource,havingahexapolelenswasemployedfor
ESI-MS analysis [28].
Photolysis experiments were carried out with a 1000W
Xenon lamp in an Oriel, model 68820, Universal Arc.
Lamp source was selected with appropriate interference ﬁlter
(Corning).
Cyclic voltammetric (CV) measurements were per-
formed in a single compartment cell with a three electrode
conﬁguration on a Pine AFCBP1 (pine Instrument Com-
pany, Groove City, PA, USA). Glassy carbon was the working
electrode,andthereferenceelectrodewasasaturatedcalomel
electrode (SCE). A platinum wire was used as the counter
electrode.
All the experiments involving interaction of the com-
plexeswithDNAwereconductedintwicedistilledphosphate
buﬀer (Titrisol, 5mM) and NaCl (4mM) and adjusted to
pH = 7.00 or 5.00 with hydrochloric acid. A solution of
calf thymus DNA (CT-DNA) in the buﬀer gave a ratio
of UV absorbance at 260 and 280nm of ca. 1.8-1.9:1,
indicating that the DNA was suﬃciently free of protein [29].
The concentration of DNA in nucleotide phosphate was
determined by UV absorbance at 260nm after dilution. The
extinction coeﬃcient, ε260 was taken as 6600M
−1 cm−1 [29].
Stock solutions were stored at 4◦Ca n du s e da f t e rn om o r e
than 4d. Supercoiled plasmid pBR322 DNA was stored at
−20◦C and its concentrationin base pairs was determined by
UV absorbance at 260nm after appropriate dilutions taking
ε260 as 13 100M
−1 cm−1.
2.3. DNA Binding Studies. Thermal denaturation experi-
ments were performed with a Varian Cary 300 spectropho-
tometer. Samples for Tm measurements were obtained by
adding 100μL of a freshly prepared stock solution of
rhenium compound, dissolved in the buﬀer (4MmNaCl,
0.096MKH2PO4,0 . 2 M N a 2HPO4, pH 5.0 or 4mMNaCl,
0.026MKH2PO4, 0.041MNa2HPO4, pH 7.0), to 1.00mL of
a calf thymus DNA solution (60μg/mL) and incubating at
25
◦C for 24 hours. As the solubility of compound 1 is poor
in net water, it was ﬁrstly dissolved in MeOH (in any case the
ratio of MeOH:water is no higher than 5:95). Under these
circumstances, complex 1 is stable for at least a period of ﬁve
days. Absorbance versus temperature proﬁles of DNA were
measured at 258nm in the temperature range from 25
◦Ct o
95
◦C.Temperaturewasraisedin0.5◦Cincrements,andDNA
complex samples were allowed to equilibrate for 1 minute at
each temperature. The melting temperature (Tm)o fD N A
was determined as the middle point of the hyperchromic
transition. To correct the absorbance spectrum of DNA from
the contribution of each of the studied compounds, theBioinorganic Chemistry and Applications 3
buﬀer solution of the corresponding complex at the same
concentration in the sample was used as a blank.
Viscosity measurements were carried out using a Schott
Ger¨ ate AVS 310 viscometer maintained at a constant temper-
ature at 25.0(±0.1)
◦C in a thermostatic bath. DNA samples
with approximately 200 base pairs in average length were
prepared by sonication in order to minimize complexities
arising from DNA ﬂexibility. Flow time was measured with
a digital stopwatch, while each sample was measured three
times, and an average ﬂow time was calculated. Data are
presented as (η/η0)
1/3 versus 1/r,w h e r er = [DNA]/[complex
1], η is the viscosity of DNA in the presence of complex, and
η0 istherelativeviscosityofDNAalone.Therelativeviscosity
of DNA in the presence and absence of the metal complex
was calculated using the expression η = (t − t0)/t0,w h e r e
t is the observed ﬂow time of the DNA solution and t0 the
ﬂow rate of buﬀer alone. According to Cohen and Eisenberg
[30] the relationship between the relative solution viscosity
(η/η0) and contour length (L/L0) is given by the equation
L/L0 = (η/η0)
1/3,w h e r eL0 denotes the apparent molecular
length in the absence of the metal complex.
2.4. DNA Photocleavage. For the gel electrophoresis experi-
ment, pBR322 supercoiled plasmid DNA (0.1lg) was treated
with the Re (V) complexes in 50mM Tris-acetate, 18mM
NaCl buﬀer (pH 7.2), and the solution was then irradiated
at room temperature with a light >400nm (100W) inside a
photoreactor. The samples were analyzed by electrophoresis
for 1 hour at 100V in Tris-acetate buﬀer containing 1%
agarose gel. The gels were imaged with a BioSure UV-
Transilluminator and photographed using a Picture Works
Photo Enhancer v3.2 digital camera equipped with a
10μg/mL ethidium bromide ﬁlter.
2.5. Synthesis of Complexes. In this context, rhenium (V)
metal complexes with bidentate (N,N) type ligands as 2-
(2 pyridyl)quinoxaline (pq) 4,2 , 2  -bipyridine (bpy) 5,a n d
1,10-phenanthroline (phen) 6, have been amply studied.
Ligands 5 and 6 were purchased by Aldrich and used
as received, whereas ligand 4 was synthesized according to
published procedures [26, 31].
2.5.1. Synthesis of [ReOCl3pq] (1). Potassium perhenate
(KReO4) was used as a starting material. A solution of
triphenylphosphine (PPh3) (5.15g, 18mmol) in hot ethanol
(29mL) was added in a boiling mixture of potassium
perhenate (1g, 3.4mmol), hydrochloric acid 37% (5.72mL),
and ethanol (5.72mL). A yellow solid precipitates. The
mixture was reﬂuxed for 30 minutes and after cooling to
room temperature, the yellow precipitate was ﬁltered oﬀ,
washed with ethanol, and dried in vacuo. By this procedure
the precursor [ReOCl3(PPh3)2] was obtained. The ligand pq
was added in a solution of [ReOCl3(PPh3)2] in dry methanol
(20mL) under stirring, and the mixture was heated to
continuous reﬂux for 24 hours at 50◦C. After cooling to
room temperature, the resultant dark purple precipitate was
ﬁltered oﬀ, washed with diethylether, and dried in vacuo.
Yield: 57%. (0.732g) 1HNMR (300MHz; CD3OD; s,
singlet; d, doublet; t, triplet; m, multiplet): δ 9.73(s, 1H,
H3pq), 8.15, 8.25(mt, 2H, H7−10pq), 7.92(mt, 2H, H8-9pq),
7.48(d, 1H, H16pq, J =8.0), 8.08(mt, 1H, H15pq), 8.91(mt,
1H,H14pq),8.65(d,1H,H13pq,J =5.5).Absorptionspectrum:
λmax(MeOH) =571.0nm(ε=3330M
−1cm−1),λmax(MeOH)
= 732.1nm (ε=1227M
−1cm−1). FT-IR spectrum: 939(vs)
cm−1 (νRe=O), 1630(m,br), 1580(w) and 1420(m) cm−1
(νC–N) and (νC=C). Anal. Calcd for ReOCl3pq: C 30.27; H
1.76; N 8.15; Cl 20.62; O 3.10. Found: C 30.97; H 1.74; N
8.19%. ES-MS (CH3CN: m/z (M—H+) 516.8.
2.5.2. Synthesis of [ReOCl3bpy] (2). This compound was
preparedbyreﬂuxing[ReOCl3(PPh3)2](0.83g,1mmol)and
bpy (1.3mmol) in methanol (50mL) for 6 hours using the
procedure employed for 1. A red microcrystalline material
was isolated.
Yield: 88%. (0.554g) 1HNMR (300MHz; CD3COCD3;
s, singlet; d, doublet; t, triplet; m, multiplet): δ 9.09(d,
2H, H6−9bpy, J = 7.9), 8.03(d, 2H, H12−13bpy, J = 5.9),
7.84(t, 2H, H4−11bpy), 7.37(t, 2H, H5−10bpy). Absorption
spectrum: λmax(MeOH) = 480.8nm (ε = 3430M
−1cm−1),
λmax(MeOH) = 750.2nm (ε = 1450M
−1cm−1), FT-IR spec-
trum: 988cm−1 (νRe=O), 1640–1570cm−1 (νC=C, (bpy)).
Anal.CalcdforReOCl3bpy:C25.84;H1.74;N6.03;Cl22.89;
O 3.44. Found: C 26.03; H 1.79; N 6.19%. ES-MS (CH3CN:
m/z (M—Cl
+) 465.9.
2.5.3. Synthesis of [ReOCl3phen] (3). This compound was
prepared by reﬂuxing ReOCl3(PPh3)2 (0.83g, 1mmol) and
phen (0.26g 1.3mmol) in methanol (50mL) for 48 hours
using the procedure employed for 1. A dark red microcrys-
talline material was isolated.
Yield: 84%. (0.843g) 1HNMR (300MHz; CD3COCD3;
s, singlet; d, doublet; t, triplet; m, multiplet): δ 8.90(d, 2H,
H2-9phen,J = 6.9), 8.37(d, 2H, H4-11phen), 7.40(s, Hphen),
7.69(mt, Hphen). Absorption spectrum: λmax(MeOH) =
459.6nm (ε = 3200M−1 cm−1), λmax(MeOH) = 739.6nm
(ε = 1100M−1 cm−1), FT-IR spectrum: 985cm−1 (νRe=O),
1628(w),1605(m),1575(w),1520(m)cm−1 (νCNandνC=C,
(phen)). Anal. Calcd for ReOCl3phen: C 29.37; H 2.05; N
5.71; Cl 21.67; O 3.26. Found: C 30.03; H 2.17; N 5.99%. ES-
MS (CH3CN: m/z (M—Cl+) 489.8.
3. Results and Discussion
3.1. Synthesis. 2-(2 pyridyl)quinoxaline (pq) is produced via
an unusual condensation reaction from 2-acetylpyridine
and 1,2-diaminobenzene and has been extensively stud-
ied because of its rich coordination chemistry. 2-(2 pyr-
idyl)quinoxaline belongs to the general class of quinoxalines
which are natural products, used as antibiotics and form
polymers with peculiar magnetic and electric properties.
Their signiﬁcant redox chemistry and photochemistry are
responsible for many considerable intra and intermolecular
electron transfer organic and biochemical processes. The
aforementioned ligand as well as bpy and phen has been
coordinated to the oxorhenium moiety.4 Bioinorganic Chemistry and Applications
The most signiﬁcant m/z peaks in ESI-mass spectra of
complexes 1–3 are given in the Synthesis Section. They
correspondtothemolecularweightofthecomplexincreased
byoneunitforcomplex 1,sothat[M-H+]formisattribut ed,
implying that a proton has been attached on the N(3) atom
of the quinoxaline ring. On the other hand, complexes
2 and 3 eliminate a -Cl atom providing the form [M-
Cl]
+. Surprisingly, we were not able to isolate crystalline
complex from the oxorhenium-quinoxaline system in which
only the typical chelate bonding of an α-diimine ring is
present. In fact, up to now only few oxorhenium-α-diimine
crystal structures have appeared in the literature though it is
well-known that radioactive 186Re and 188Re are important
diagnostic nuclear agents. Actually, the crystal structure
of the ReOCl3phen was recently reported [32]. According
to the data presented therein, the rhenium atom is in a
distorted octahedral environment with the three chloride
ligands arranged in a meridional fashion and the oxo ligand
trans to the nitrogen atom of the phenanthroline. As the
complexes under study 1 and 2 are isomorphous to 3,w e
expect to adopt similar geometries.
3.2. Characterization of [ReOCl3(α-diimine)] Complexes
3.2.1. Infrared Data. The IR spectra of 1, 2,a n d3 exhibit
very strong bands at 939, 988, and 985cm−1,r e s p e c t i v e l y ,
assignable to the ν(Re=O) mode. These values compare well
with those reported for rhenium (V) complexes containing
a chelating ligand in their coordination sphere [32]. The
characteristicbandscorrespondingtotheν(CN)andν(C=C)
modes of the quinoxaline and diimine ligand appear in the
range 1680–1420cm−1 in the IR spectra of the complexes 1–
3 [20, 25, 32].
3.2.2. NMR Spectroscopy. The oxorhenium complexes 1–3
give well-deﬁned 1H-NMR spectra, which permit unam-
biguous identiﬁcation and assessment of purity. The proton
chemical shifts are assigned with the aid of 1H-COSY
experiments (provided in Section 2).
It is worth to discuss the complexation of 2-(2 
pyridyl)quinoxaline to the [ReOCl3(PPh3)2] moiety since it
entailstwomajorchanges:theﬁrstinvolvestheconﬁguration
of 2-2 pq switching from the syn/cis- to the anti/trans-
conformation, while the second is related to the withdrawal
of its electron density by the metal. These changes are
reﬂected on the NMR spectra of the complex. Figure 2
displays the 1H–1H COSY spectra of the free ligand L and
of the complex, which are important for assigning of the 1D-
NMR peaks.
The NMR spectrum of the coordinated ligand L diﬀers
from that of the free ligand (Figure 2) mainly due to the
separation of H5 and H8 signals and to an overall downﬁeld
shift. The latter is due to the reducing electron charge of the
protons after coordination of the ligand. The most downﬁeld
shifted peak remains the H3(s) [31]. The same switching
from syn/cis- to the anti/trans-conformation is also observed
in the spectrum due to the complexation of 2-2 -bipyridine
ligand.
Table 1: Electrochemical and absorption data of the oxorhenium
(V) complexes.
Complex
E1/2/Vv e r s u sS C E
a λmax/nm
(ε/M
−1cm−1)
b
λmax/nm
(ε/M
−1cm
−1
)
c
Epa (V) Epc (V)
[ReOCl3pq]
(1)
−0.52 −0.70
268.5 (4835) 272.4 (4820)
571.0 (3330) 581.2 (3520)
732.1 (1227) 738.3 (1337)
[ReOCl3bpy]
(2)
−0.54 −0.72
295.3 (4315) 294.1 (4330)
480.8 (3430) 493.0 (3520)
750.2 (1450) 753.0 (1480)
[ReOCl3phen]
(3)
−0.44 −0.61
270.6 (4580) 268.3 (4350)
459.6 (3200) 463.7 (3300)
739.6 (1100) 745.0 (1150)
aAll complexes were measured in 0.1M TBABF4-DMF; error in potential
was ±0.01V; T = 25 ± 0.2◦C; scan rate = 100mV · s−1
bIn CH3OH, [C] = 10−2 M
cIn CH3COCH3,[ C ]= 10−2 M.
3.2.3. UV-Vis Spectroscopy. The electronic absorption spec-
tra of [ReOCl3(α-diimine)] in the area between 300 and
800nm are shown in Table 1. The UV-Vis spectra of 1–3
exhibit few intense bands in the range of 570–200nm and
a weak absorption in the low range 730–750nm. Accord-
ing to TD-DFT calculations [32], the longest wavelength
experimental band of 1, 2,a n d3 at 732, 750, and 739nm,
respectively,isattributedtothetransitionofd → dcharacter.
The broad MLCT absorption band appears at 571, 480, and
459nm for complexes 1, 2,a n d3, respectively. It originates
from the dRe orbitals to the π
∗
α−diimine orbitals [32] and it
is blue shifted in less polar solvents (Table 1), indicating
its charge transfer character. The higher energy absorp-
tion bands at UV region are attributed to ligand-ligand
charge transfer transitions, namely, (π)Cl/(π)O/(π)diimine
→ π∗(diimine), interligand transitions.
3.2.4. Electrochemical Behaviour of Complexes. The redox
properties of the compounds 1–3 have been investigated
by cyclic voltammetry, at a Pt electrode, usually in a 0.1M
TBABF4-DMF solution at 25 ± 0.2
◦C, and the measured
redox potentials (in V versus SCE) are given in Table 1.
Solutions were deoxygenated by purging with argon gas for
15 minutes prior to the measurements; during the measure-
ments a stream of argon was passed over the solution. All the
studied complexes exhibit (Table 1)ar e d u c t i o nw a v ew h i c h
is usually followed, at the lowest potential, by a second one.
These waves often correspond to single-electron reversible
processes, being assigned to the d
n → d
n+1 and d
n+1 →
d
n+2 metal reductions. Previous studies have shown that
the diimine ligand inﬂuences the reduction potential of the
compounds. The oxidation for all three complexes occurs at
very similar potentials. Both reduction potentials occur at
negative potentials.Bioinorganic Chemistry and Applications 5
Table 2: Melting temperatures of CT-DNA in 10mM buﬀer (pH 7.0 and pH 5.0) in the presence of complexes 1–3, before and after
irradiation (λ = 420–1000nm).
C.T.-DNA +a R = 0.025 R = 0.050 R = 0.025∗ R = 0.050∗
pH Tm
◦C ΔTm %hyp Tm
◦C ΔTm %hyp Tm
◦C ΔTm %hyp Tm
◦C ΔTm %hyp
[ReOCl3pq] 7.0 80.1 +9.2 18.0 81.8 +10.9 13.0 77.9 +7.0 12.0 79.1 +9.0 12.0
(1) 5.0 81.1 +8.0 27.0 80.2 +7.1 19.0 78.1 +5.0 28.0 79.1 +6.0 19.0
[ReOCl3bpy] 7.0 76.9 +6.0 44.0 76.9 +6.0 39.0 75.4 +4.5 45.0 75.1 +5.0 36.0
(2) 5.0 76.1 +3.0 20.0 77.1 +4.0 20.0 73.1 +0.0 20.0 76.1 +3.0 20.0
[ReOCl3phen] 7.0 71.1 +0.2 71.4 +0.5 70.9 +0.0 74.2 +0.3
(4) 5.0 73.1 +0.0 73.3 +0.2 73.1 −0.0 73.1 +0.0
∗Illuminated samples. aThe melting point of the free CT-DNA is 70.9◦C (pH 7.0) and 73.1◦C (pH 5.0).
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Figure 2: COSY-NMR spectra of pq (a) and [ReOCl3pq] (b) in methanol.
3.3. Biological Assays
3.3.1. Tm Measurements. The study of the melting curves of
C.T.-DNA indicates that the interaction of DNA with the
oxorhenium (V) complexes 1 and 2, leads to the stabilization
ofthedoublehelixinproportiontotheratior = [ReOCl3(α-
diimine)]/[CT-DNA] (Table 2). The stabilization can be
assumed by the raising of the Tm w h i c hi sﬁ n a l l yo b s e r v e d
in analogy with r, reaching at +10.85
◦Cf o r1 at r = 0.05 and
pH = 7.0( Figure 3). In the presence of all three complexes
(1–3) the thermal stabilization of CT-DNA is observed in
the series 1 > 2 > 3. Moreover, the reduction of the ﬁnal
hyperchromicity and the decrease of the slope of melting
curves (increase of the transition) provide a strong evidence
of the interaction which leads to DNA helix stabilization
[33]. “Premelting eﬀects” of the double helix which could
be caused by the binding of oxorhenium (V) complexes,
p r o b a b l yv i aa l l o s t e r i ce ﬀects, are rather not taking place
since they would result in DNA helix destabilization [34].
The reversibility measurements of the 1 and 3 binding to
CT-DNA (cooling the samples and reheating them) showed
completely super-imposable results onto the ﬁrst heating
scans. This suggests that the species present in the solution
of 1 or 3, do not alone inhibit reannealing, associating
irreversibly with the single strand which is similar to the
results obtained for the free ligands. Although the complex
[ReOCl3phen] is isostructural to the complexes [ReOCl3pq]
and [ReOCl3bpy], it presents diﬀerent behaviour when
interacts with CT-DNA. In both buﬀered pH 7.0 and pH
5.0 solutions, at all ratios, the melting points of CT-DNA
are almost the same with free CT-DNA. Identical results
have been obtained when CT-DNA was treated with all free
ligands under investigation. So we can conclude that there is
almost no interaction between the complex [ReOCl3phen]
and CT DNA. No observable changes are measured after
irradiation.
3.3.2. CV Studies. Electrochemical investigation of complex-
DNA interactions can provide a useful complement to
other methods and yield information about the mechanism
of the interaction [23, 24, 35]. Figure 4 shows the cyclic
voltammograms of the complex at the absence and the
presence of DNA. A new irreversible redox peak appeared6 Bioinorganic Chemistry and Applications
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Figure 3: Thermal denaturation curves of C.T.-DNA in the
presence of the complex ReOCl3pq before and after irradiation at
increasing molar ratios r,p H= 7.0.
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Figure 4: Cyclic voltagramm of 1( 0.1mM). (a) in the absence and
(b) in the presence of DNA. Supporting electrolyte 0.1mM TBABF4
in DMF.
after the addition of CT DNA to complex 1, whereas the
intensity of all peaks decreased signiﬁcantly, suggesting the
existence of an interaction between 1 and CT DNA. The
observed decrease in current can be attributed both to the
intercalation of complex 1 into the base pairs of DNA by
the planar pq ligand [23, 24] and to an equilibrium mixture
of free and DNA-bound complex to the electrode surface
[35]. The experimental results are diﬀerent for 2,w h e r e
the current intensity of all the peaks decreased signiﬁcantly
after addition of CT DNA, and for 3 where no changes are
observed in its cyclic voltammogram implying that complex
3 does not interact with DNA.
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Figure 5:Eﬀectofincreasingamountsofcomplex1(0–100μM)on
the relative viscosity of CT-DNA (100μM).
3.3.3. Viscosity Measurements. Optical photophysical probe
providesnecessarybutnotsuﬃcientcluestosupportbinding
modes [24, 36], whereas hydrodynamic measurements that
are sensitive to the length change are regarded as the most
critical tests of a binding model in solution. Thus, to further
clarify the interaction between 1 and DNA, we carried
out viscosity measurements. Because the latter are ionic-
strength-and-concentration dependent, we used a buﬀer of
the same ionic strength for all measurements. Figure 5 shows
the relative viscosity of DNA (100lM) in the presence of
varying amounts of complex 1. As we observe, the relative
viscosity increases from 0.98 to 1.14 in relative low ratios,
[complex]/[DNA], while it remains almost constant there
after.Theobservedincreaseisatthesameextentwiththeone
observed when an intercalator is used, for example ethidium
bromide—a well known intercalator, at the same ratios as
complex 1 [24, 37]. This behaviour suggests that complex
1 intercalates to CT-DNA in accordance with the previous
results.
3.3.4. DNA Photocleavage. The ability of complex 1 to
cleave DNA upon irradiation was determined by agarose
gel electrophoresis [38]. When circular plasmid DNA in
the presence of an inorganic molecule is subject to elec-
trophoresis, relatively fast migration will be observed for
the intact supercoil form (Form I). If scission occurs on
one strand (nicking), the supercoil will relax to generate a
slower-moving open circular form (Form II). If both strands
are cleaved, a linear form (Form III) that migrates between
F o r m sIa n dI Iw i l lb eg e n e r a t e d[ 38]. Figure 6 shows gel
electrophoresis separation of pBR 322DNA after incubation
with complex 1 and irradiation by visible light (λ>400nm)
for 1 hour. Complex 1 exhibited concentration-dependent
single-strand cleavage of supercoiled Form I into nicked
Form II. Control experiment (lane 0) suggests that untreated
DNA does not show any cleavage upon irradiation, with
increasing concentration of 1 (lanes 1–3); the amount
of Form I of pBR322DNA diminishes gradually, whereasBioinorganic Chemistry and Applications 7
01234
Form II
Form I
Figure 6: Photoactivated cleavage of pBR 322DNA in the presence
of Re(V) complex, light after 60 minutes irradiation at λ>400nm.
Lane 0, DNA alone; lanes 1–4, in the diﬀerent concentrations of
complex 1: (1) 0; (2) 20; (3) 40; (4) 60lM.
012345
Form II
Form I
Figure 7: Photoactivated cleavage of pBR 322DNA in the presence
of 20μMo fc o m p l e x1 and diﬀerent inhibitors after irradiation
at λ>400nm for 60 minutes. Lane 0, DNA control; lane 1, no
inhibitor; lanes 2–6: (2) histidine (5mM), (3) DMSO (0.2M), (4)
ethanol (0.2M), (5) sodium formate (5mM).
that of Form II increases. Under comparable experimental
conditions, complex 2 exhibits more eﬀective DNA cleavage
activity than complex 1. In order to identify the nature of the
reactive species that are responsible for the photo-activated
cleavage of the plasmid DNA, we further investigated the
inﬂuence of diﬀerent potentially inhibiting agents. In the
case of complex 1 (Figure 7), studies with the single oxygen
quencherhistidine werecarried outand the plasmid cleavage
was inhibited (lane 2), which conﬁrmed that the singlet
oxygen was involved in the cleavage. At the same time, in
the presence of diﬀerent hydroxyl radical scavengers such as
DMSO (lane 3), ethanol (lane 4) and sodium formate (lane
5),diﬀerentdegreesofinhibitioninthephoto-inducedcleav-
age of the plasmid by complex 1 were also observed. This
indicates that hydroxyl radical also plays a signiﬁcant role in
the photocleavage mechanism for 1, and the photoreduction
of ReO complexes with concomitant hydroxide oxidation is
an important step in the DNA cleavage reaction [38].
4. Conclusions
In summary, a new oxorhenium (V) complex namely,
[ReOCl3pq] (1) together with its isostructural [ReOCl3bpy]
(2) and [ReOCl3phen] (3) has been synthesized and char-
acterized by elemental analyses, FT-IR, UV-Vis spectra,
1D, and 2D NMR, ESI-MS, and CV. The interactions
between complexes 1–3 (as well as all a-diimine ligands)
and calf thymus DNA have been investigated using UV-
spectra, thermal denaturation measurements, CV, and vis-
cosity measurements. Furthermore, the photocleavage of the
plasmid pBR 322DNA has been investigated by agarose gel
electrophoresis. Remarkably, our results reveal that both
complexes 1 and 2 bind to DNA by intercalation, with the
planar diimine (pq or bpy) ligands stacked between the
base pairs of the DNA. Complex 1 can eﬃciently cleave the
plasmidpBR322DNA,uponirradiationwhereasthereactive
species responsible for its cleavage are the singlet oxygen and
the hydroxyl radical. The thermal stabilization of DNA is
reversed to the promoted photocleavage at physiological pH
and temperature, indicating the diﬀerences in interactions
between the base pairs of DNA and the ground or the
excited state of the complexes. Similar observations have
also been reported for rhenium (I) complexes [39, 40].
These complexes may be useful to probe nucleic acid
structures and in the development of DNA agents. More
detailed photophysical and biophysical studies designed to
address the nature of the interactions of oxorhenium (V) are
underway.
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